Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacity.
暂无分享,去创建一个
B. Wolf | G. Morris | A. Shug | D. Paulson | D. Didomenico | S. Christos | Q. Zhou
[1] B. Wolf,et al. Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency. , 1995, Metabolism: clinical and experimental.
[2] R. Barnard,et al. Exercise capacity of rats remains unaffected by a chronic pressure overload. , 1993, Cardiovascular Research.
[3] F. Haddad,et al. Food restriction-induced transformations in cardiac functional and biochemical properties in rats. , 1993, Journal of applied physiology.
[4] Q. Diep,et al. Reduced carnitine and ketogenesis in the pivampicillin treated rat. , 1992, Biochemical pharmacology.
[5] R. Jacob,et al. Metabolically-modulated growth and phenotype of the rat heart. , 1992, European heart journal.
[6] S. Lobatto,et al. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. , 1992, Contributions to nephrology.
[7] N. Dhalla,et al. Modification of subcellular organelles in pressure‐overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] H. Quinney,et al. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. , 1992, The Journal of biological chemistry.
[9] A. Davis,et al. Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats. , 1991, The Journal of nutrition.
[10] G. Morris,et al. Dietary effects on cardiac metabolic properties in rodents. , 1990, Journal of molecular and cellular cardiology.
[11] S. Lindstedt,et al. CARNITINE DEFICIENCY INDUCED BY PIVAMPICILLIN AND PIVMECILLINAM THERAPY , 1989, The Lancet.
[12] L L Ji,et al. Carnitine supplementation and depletion: tissue carnitines and enzymes in fatty acid oxidation. , 1987, Journal of applied physiology.
[13] M. Schmidt,et al. Improvement of myocardial function in diabetic rats after treatment with L-carnitine. , 1984, Metabolism: clinical and experimental.
[14] J. Bremer. Carnitine--metabolism and functions. , 1983, Physiological reviews.
[15] S. Dimauro,et al. Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. , 1982, The Journal of pediatrics.
[16] R. Bressler,et al. Metabolic Control of Prevention of Nephropathy by 2-Tetradecylglycidate in the Diabetic Mouse (db/db) , 1982, Diabetes.
[17] J. Hoh,et al. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. , 1978, Journal of molecular and cellular cardiology.
[18] J. McGarry,et al. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. , 1976, Journal of lipid research.
[19] E. Newsholme,et al. Inhibition of the Phosphofructokinase Reaction in Perfused Rat Heart by Respiration of Ketone Bodies, Fatty Acids and Pyruvate , 1962, Nature.
[20] J. C. Finerty,et al. Effects of a rat-free diet on growing female rats with special reference to the endocrine system. , 1953, The Journal of nutrition.
[21] A. L. Carter. Current concepts in carnitine research , 1992 .
[22] B. Sempore,et al. Large variations in skeletal muscle carnitine level fail to modify energy metabolism in exercising rats. , 1990, Comparative biochemistry and physiology. A, Comparative physiology.
[23] C. Rebouche,et al. Carnitine metabolism and function in humans. , 1986, Annual review of nutrition.
[24] W. Dillmann. Diabetes mellitus and hypothyroidism induce changes in myosin isoenzyme distribution in the rat heart--do alterations in fuel flux mediate these changes? , 1986, Advances in experimental medicine and biology.